Apple wins appeal before the US Court of Appeals for a measure that prevented the sale of a digital watch – El Sol de México

Manzana a victory was scored on Wednesday, when a United States Court of Appeals suspended the import ban on some of its popular smart watchess by a government commission following a patent dispute with the company Masimo medical technology.

The technology giant had filed an emergency request for the United States Court of Appeals for the Federal Circuit stopped the order after appealing the decision of the United States International Trade Commission (ITC) that it had infringed the patents of Masimo.

On December 26, the Government of the president Joe Biden he refused to veto the ban, allowing it to take effect. The same day, Manzana requested the suspension of the ban.

Masimo has accused Manzana to hire their employees, steal their pulse oximetry technology and incorporate it into the AppleWatch.

The ITC prohibited imports and sales of Apple Watch with technology to read blood oxygen levels.bha included a pulse oximetry feature in yours smart watches starting with its Series 6 model in 2020.

Manzana has suspended sales of its Series 9 and Ultra 2 smart watches in the United States, although the devices have continued to be available at other retailers, such as Amazon, Best Buy, Costco and Walmart.

The ban does not affect the Apple Watch SE, a cheaper model without a pulse oximeter. Previously sold watches will also not be affected by the ban.

A jury trial on the allegations of Masimo against Apple in federal court in California ended with a mistrial in May. Manzana has separately sued Masimo for patent infringement in federal court in Delaware and has called the legal actions Masimo from “maneuver to clear the way” to your own smartwatch.

➡️ Join the El Sol de México channel on WhatsApp so you don’t miss the most important information

The wearables, home and accessories business Manzanawhich includes the Apple Watch, earphonesIt’s AirPods and other products, obtained revenues of $8.28 billion during the third quarter of 2023, according to a company report.

Leave a Reply

Your email address will not be published. Required fields are marked *